Clinical trial
Losartan Versus Hydrochlorothiazide in Reversing Remodeling of Small Arteries in…
NCT00388388 · Sir Mortimer B. Davis - Jewish General Hospital, Other · Terminated
Key facts
| NCT number | NCT00388388 |
|---|---|
| Title | Losartan Versus Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic Subjects |
| Official title | Double-blind, Randomized, Parallel Design Study Comparing Effectiveness of Losartan vs. Hydrochlorothiazide in Reversing or Preventing the Progression of the Remodeling of Resistance Arteries in Pre-hypertensive Pre-diabetic Subjects |
| Lead sponsor | Sir Mortimer B. Davis - Jewish General Hospital, Other |
| Collaborators | Merck Frosst Canada Ltd. Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pre-hypertension, Pre-diabetes |
| Intervention type | Drug |
| Interventions | losartan, hydrochlorothiazide |
| Enrollment | 1 |
| Start date | Mar 1, 2007 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Oct 16, 2006 |
| Last update posted | May 19, 2015 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: